The Role of Toll-Like Receptors and Vitamin D in Diabetes Mellitus Type 1 - A Review

Scandinavian Journal of Immunology

Volumn 80, Issue 2, 2014, Pages 75-84

  Adamczak, D M ^a   Nowak, J K ^a   Frydrychowicz, M ^a   Kaczmarek, M ^a   Sikora, J ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR; TOXIN; VACCINE; VITAMIN D;

BIOBREEDING RAT; BREAST FEEDING; CLIMATE CHANGE; ENTEROVIRUS INFECTION; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; HYGIENE; IMMUNE SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; MENTAL STRESS; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; REVIEW; RODENT MODEL; VIRUS INFECTION; VITAMIN D DEFICIENCY;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MICE; RATS; RECEPTORS, CALCITRIOL; TOLL-LIKE RECEPTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84903902041     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12188     Document Type: Review

References (111)

1. Mathis D, Vence L, Benoist C. Beta-Cell death during progression to diabetes. Nature 2001;414:792-8.
2. Ellerman KE, Like AA. Susceptibility to diabetes is widely distributed in normal class IIu haplotype rats. Diabetologia 2000;43:890-8.
3. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965;14:619-33.
4. Bortell R, Pino SC, Greiner DL, Zipris D, Rossini AA. Closing the circle between the bedside and the bench: toll-like receptors in models of virally induced diabetes. Ann N Y Acad Sci 2008;1150:112-22.
5. Skyler JS. Immune intervention for type 1 diabetes mellitus. Int J Clin Pract Suppl 2011;170:61-70.
6. Johnson GB, Brunn GJ, Tang AH, Platt JL. Evolutionary clues to the functions of the Toll-like family as surveillance receptors. Trends Immunol 2003;24:19-24.
7. Oldenburg M, Krüger A, Ferstl R, Kaufmann A, Nees G, Sigmund A et al. TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. Science 2012;337:1111-5.
8. Doan T. Immunology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2008. ISBN-13: 978-1451109375.
9. Seong S-Y, Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 2004;4:469-78.
10. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010;11:373-84.
11. Lien E, Zipris D. The role of Toll-like receptor pathways in the mechanism of type 1 diabetes. Curr Mol Med 2009;9:52-68.
12. Yamamoto M. Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway. Science 2003;301:640-3.
13. Harkness LS, Bonny AE. Calcium and vitamin D status in the adolescent: key roles for bone, body weight, glucose tolerance, and estrogen biosynthesis. J Pediatr Adolesc Gynecol 2005;18:305-11.
14. Holick MF, Vitamin D. Deficiency. N Engl J Med 2007;357:266-81.
15. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80 (6 Suppl.):1678S-88S.
16. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006;81:353-73.
17. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008;87:1080S-6S.
18. Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 2004;158:531.
19. Institute of Medicine (US). Committee to review dietary reference intakes for vitamin D and calcium. In: Ross AC, Taylor CL, Yaktine AL, Del ValleHB, eds. Dietary Reference Intakes for Calcium and Vitamin D [Internet]. Washington, DC: National Academies Press, 2011: 362-3. ISBN:978-0-309-16395-8.
20. Hanley DA, Cranney A, Jones G, Whiting SJ, Leslie WD, Cole DEC et al. Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ 2010;182:E610-8.
21. Glade MJ. A 21st century evaluation of the safety of oral vitamin D. Nutrition 2012;28:344-56.
22. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2014;2:76-89.
23. Karvonen M, Cepaitis Z, Tuomilehto J. Association between type 1 diabetes and Haemophilus influenzae type b vaccination: birth cohort study. BMJ 1999;318:1169-72.
24. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G; EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009;373:2027-33.
25. Redondo MJ, Jeffrey J, Fain PR, Eisenbarth GS, Orban T. Concordance for islet autoimmunity among monozygotic twins. N Engl J Med 2008;359:2849-50.
26. Oresic M, Simell S, Sysi-Aho M, Näntö-Salonen K, Seppänen-Laakso T, Parikka V et al. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med 2008;205:2975-84.
27. Nguyen C, Varney MD, Harrison LC, Morahan G. Definition of high-risk type 1 diabetes HLA-DR and HLA-DQ types using only three single nucleotide polymorphisms. Diabetes 2013;62:2135-40.
28. Pociot F, Akolkar B, Concannon P, Erlich HA, Julier C, Morahan G et al. Genetics of type 1 diabetes: what's next? Diabetes 2010;59:1561-71.
29. Noble JA, Valdes AM, Varney MD, Carlson JA, Moonsamy P, Fear AL et al. HLA class I and genetic susceptibility to type 1 diabetes: results from the type 1 diabetes genetics consortium. Diabetes 2010;59:2972-9.
30. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009;41:703-7.
31. Steck AK, Wong R, Wagner B, Johnson K, Liu E, Romanos J et al. Effects of non-HLA gene polymorphisms on development of islet autoimmunity and type 1 diabetes in a population with high-risk HLA-DR, DQ genotypes. Diabetes 2012;61:753-8.
32. Van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 2011;91:79-118.
33. Hober D, Alidjinou EK. Enteroviral pathogenesis of type 1 diabetes: queries and answers. Curr Opin Infect Dis 2013;26:263-9.
34. Norris JM, Beaty B, Klingensmith G, Yu L, Hoffman M, Chase HP et al. Lack of association between early exposure to cow's milk protein and beta-cell autoimmunity. Diabetes Autoimmunity Study in the Young (DAISY). JAMA 1996;276:609-14.
35. Hummel M, Füchtenbusch M, Schenker M, Ziegler AG. No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB Study. Diabetes Care 2000;23:969-74.
36. Lönnrot M, Salminen K, Knip M, Savola K, Kulmala P, Leinikki P et al. Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol 2000;61:214-20.
37. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001;358:221-9.
38. Rose K, Penna-Martinez M, Klahold E, Kärger D, Shoghi F, Kahles H et al. Influence of the vitamin D plasma level and vitamin D-related genetic polymorphisms on the immune status of patients with type 1 diabetes: a pilot study. Clin Exp Immunol 2013;171:171-85.
39. Mohr SB, Garland CF, Gorham ED, Garland FC. The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 2008;51:1391-8.
40. Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 1995;61 (3 Suppl.):638S-45S.
41. De Goffau MC, Luopajärvi K, Knip M, Ilonen J, Ruohtula T, Härkönen T et al. Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes 2013;62:1238-44.
42. Vaarala O. Gut microbiota and type 1 diabetes. Rev Diabet Stud 2012;9:251-9.
43. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009;58:1091-103.
44. Lam YY, Ha CWY, Campbell CR, Mitchell AJ, Dinudom A, Oscarsson J et al. Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS ONE 2012;7:e34233.
45. Brown CT, Davis-Richardson AG, Giongo A, Gano KA, Crabb DB, Mukherjee N et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS ONE 2011;6:e25792.
46. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008;455:1109-13.
47. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229-41.
48. Villena J, Kitazawa H. Modulation of Intestinal TLR4-Inflammatory Signaling Pathways by Probiotic Microorganisms: Lessons Learned from Lactobacillus jensenii TL2937. Front Immunol 2014;4:512.
49. Fujie H, Villena J, Tohno M, Morie K, Shimazu T, Aso H et al. Toll-like receptor-2-activating bifidobacteria strains differentially regulate inflammatory cytokines in the porcine intestinal epithelial cell culture system: finding new anti-inflammatory immunobiotics. FEMS Immunol Med Microbiol 2011;63:129-39.
50. Ooi JH, Li Y, Rogers CJ, Cantorna MT. Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. J Nutr 2013;143:1679-86.
51. McKinney PA, Okasha M, Parslow RC, Law GR, Gurney KA, Williams R et al. Early social mixing and childhood type 1 diabetes mellitus: a case-control study in Yorkshire, UK. Diabet Med 2000;17:236-42.
52. Christen U, von Herrath MG. Infections and autoimmunity-good or bad? J Immunol 2005;174:7481-6.
53. Bach J-F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911-20.
54. Hägglöf B, Blom L, Dahlquist G, Lönnberg G, Sahlin B. The Swedish childhood diabetes study: indications of severe psychological stress as a risk factor for type 1 (insulin-dependent) diabetes mellitus in childhood. Diabetologia 1991;34:579-83.
55. Caso JR, Pradillo JM, Hurtado O, Leza JC, Moro MA, Lizasoain I. Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke. Stroke 2008;39:1314-20.
56. Wasmuth HE, Kolb H. Cow's milk and immune-mediated diabetes. Proc Nutr Soc 2000;59:573-9.
57. Lempainen J, Tauriainen S, Vaarala O, Mäkelä M, Honkanen H, Marttila J et al. Interaction of enterovirus infection and cow's milk-based formula nutrition in type 1 diabetes-associated autoimmunity. Diabetes Metab Res Rev 2012;28:177-85.
58. Sane F, Alidjinou EK, Kacet N, Moukassa D, Charlet C, Ebatetou-Ataboho E et al. Human milk can neutralize Coxsackievirus B4 in vitro. J Med Virol 2013;85:880-7.
59. Knip M, Virtanen SM, Becker D, Dupré J, Krischer JP, Åkerblom HK et al. Early feeding and risk of type 1 diabetes: experiences from the Trial to Reduce Insulin-dependent diabetes mellitus in the Genetically at Risk (TRIGR). Am J Clin Nutr 2011;94 (6 Suppl.):1814S-20S.
60. Luopajärvi K, Savilahti E, Virtanen SM, Ilonen J, Knip M, Akerblom HK et al. Enhanced levels of cow's milk antibodies in infancy in children who develop type 1 diabetes later in childhood. Pediatr Diabetes 2008;9:434-41.
61. Choi YJ, Kim MK, Jeong SJ. Vitamin D deficiency in infants aged 1 to 6 months. Korean J Pediatr 2013;56:205-10.
62. Virtanen SM, Jaakkola L, Räsänen L, Ylönen K, Aro A, Lounamaa R et al. Nitrate and nitrite intake and the risk for type 1 diabetes in finnish children. Diabet Med 1994;11:656-62.
63. Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. Childhood vaccination and type 1 diabetes. N Engl J Med 2004;350:1398-404.
64. DeStefano F, Mullooly JP, Okoro CA, Chen RT, Marcy SM, Ward JI et al. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics 2001;108:e112.
65. Sajadian A, Tabarraei A, Soleimanjahi H, Fotouhi F, Gorji A, Ghaemi A. Comparing the effect of Toll-like receptor agonist adjuvants on the efficiency of a DNA vaccine. Arch Virol 2014; doi: 10.1007/s00705-014-2024-4.
66. Lee S, Mittler RS, Moore ML. Targeting CD137 enhances vaccine-elicited anti-respiratory syncytial virus CD8 + T cell responses in aged mice. J Immunol 2014;192:293-9.
67. Hober D, Sane F. Enteroviral pathogenesis of type 1 diabetes. Discov Med 2010;10:151-60.
68. Jaïdane H, Sauter P, Sane F, Goffard A, Gharbi J, Hober D. Enteroviruses and type 1 diabetes: towards a better understanding of the relationship. Rev Med Virol 2010;20:265-80.
69. Lönnrot M, Korpela K, Knip M, Ilonen J, Simell O, Korhonen S et al. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study. Diabetes 2000;49:1314-8.
70. Triantafilou K, Triantafilou M. Coxsackievirus B4-induced cytokine production in pancreatic cells is mediated through toll-like receptor 4. J Virol 2004;78:11313-20.
71. Anagandula M, Richardson SJ, Oberste MS, Sioofy-Khojine A-B, Hyöty H, Morgan NG et al. Infection of human islets of langerhans with two strains of coxsackie B virus serotype 1: Assessment of virus replication, degree of cell death and induction of genes involved in the innate immunity pathway. J Med Virol 2013; doi: 10.1002/jmv.23835.
72. Schulte BM, Lanke KHW, Piganelli JD, Kers-Rebel ED, Bottino R, Trucco M et al. Cytokine and chemokine production by human pancreatic islets upon enterovirus infection. Diabetes 2012;61:2030-6.
73. Yeung W-CG, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 2011;342:d35.
74. Yoon JW, Austin M, Onodera T, Notkins AL. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979;300:1173-9.
75. Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 2000;49:708-11.
76. Tracy S, Drescher KM. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes. Ann N Y Acad Sci 2007;1103:143-51.
77. Oldstone MB. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science 1988;239:500-2.
78. Christen U, Benke D, Wolfe T, Rodrigo E, Rhode A, Hughes AC et al. Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. J Clin Invest 2004;113:74-84.
79. Rees DA, Alcolado JC. Animal models of diabetes mellitus. Diabet Med 2005;22:359-70.
80. Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 1999;5:601-4.
81. Horwitz MS, Ilic A, Fine C, Rodriguez E, Sarvetnick N. Presented antigen from damaged pancreatic β cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J Clin Invest 2002;109:79-87.
82. Von Herrath MG, Fujinami RS, Whitton JL. Microorganisms and autoimmunity: making the barren field fertile? Nat Rev Microbiol 2003;1:151-7.
83. Dotta F, Censini S, van Halteren AGS, Marselli L, Masini M, Dionisi S et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A 2007;104:5115-20.
84. Filippi CM, Estes EA, Oldham JE, von Herrath MG. Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice. J Clin Invest 2009;119:1515-23.
85. Jaïdane H, Sané F, Hiar R, Goffard A, Gharbi J, Geenen V et al. Immunology in the clinic review series; focus on type 1 diabetes and viruses: enterovirus, thymus and type 1 diabetes pathogenesis: Enterovirus, thymus and T1D. Clin Exp Immunol 2012;168:39-46.
86. Dandona P, Ghanim H, Green K, Sia CL, Abuaysheh S, Kuhadiya N et al. Insulin infusion suppresses while glucose infusion induces toll-like receptors and high-mobility group-B1 protein expression in mononuclear cells of type 1 diabetes patients. Am J Physiol Endocrinol Metab 2013;304:E810-8.
87. Meyers AJ, Shah RR, Gottlieb PA, Zipris D. Altered toll-like receptor signaling pathways in human type 1 diabetes. J Mol Med 2010;88:1221-31.
88. Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC, Jialal I. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 2008;93:578-83.
89. Gülden E, Ihira M, Ohashi A, Reinbeck AL, Freudenberg MA, Kolb H et al. Toll-like receptor 4 deficiency accelerates the development of insulin-deficient diabetes in non-obese diabetic mice. PLoS ONE 2013;8:e75385.
90. Lee AS, Ghoreishi M, Cheng WK, Chang T-YE, Zhang YQ, Dutz JP. Toll-like receptor 7 stimulation promotes autoimmune diabetes in the NOD mouse. Diabetologia 2011;54:1407-16.
91. Zipris D, Lien E, Nair A, Xie JX, Greiner DL, Mordes JP et al. TLR9-signaling pathways are involved in Kilham rat virus-induced autoimmune diabetes in the biobreeding diabetes-resistant rat. J Immunol 2007;178:693-701.
92. Lang KS, Recher M, Junt T, Navarini AA, Harris NL, Freigang S et al. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med 2005;11:138-45.
93. Zipris D, Lien E, Xie JX, Greiner DL, Mordes JP, Rossini AA. TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats. J Immunol 2005;174:131-42.
94. Wen L, Peng J, Li Z, Wong FS. The effect of innate immunity on autoimmune diabetes and the expression of Toll-like receptors on pancreatic islets. J Immunol 2004;172:3173-80.
95. Tai N, Wong FS, Wen L. TLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice. J Immunol 2013;191:2926-37.
96. Aumeunier A, Grela F, Ramadan A, Pham Van L, Bardel E, Gomez Alcala A et al. Systemic toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice. PLoS ONE 2010;5:e11484.
97. Dong J-Y, Zhang W-G, Chen JJ, Zhang Z-L, Han S-F, Qin L-Q. Vitamin D intake and risk of type 1 diabetes: a meta-analysis of observational studies. Nutrients 2013;5:3551-62.
98. Thorsen SU, Mortensen HB, Carstensen B, Fenger M, Thuesen BH, Husemoen LL et al. No difference in vitamin D levels between children newly diagnosed with type 1 diabetes and their healthy siblings: a 13-year nationwide Danish study. Diabetes Care 2013;36:e157-8.
99. Devaraj S, Yun J-M, Duncan-Staley CR, Jialal I. Low vitamin D levels correlate with the proinflammatory state in type 1 diabetic subjects with and without microvascular complications. Am J Clin Pathol 2011;135:429-33.
100. Giarratana N, Penna G, Amuchastegui S, Mariani R, Daniel KC, Adorini L. A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. J Immunol 2004;173:2280-7.
101. Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001;358:1500-3.
102. Alvarez-Rodriguez L, Lopez-Hoyos M, Garcia-Unzueta M, Amado JA, Cacho PM, Martinez-Taboada VM. Age and low levels of circulating vitamin D are associated with impaired innate immune function. J Leukoc Biol 2012;91:829-38.
103. Murillo G, Nagpal V, Tiwari N, Benya RV, Mehta RG. Actions of vitamin D are mediated by the TLR4 pathway in inflammation-induced colon cancer. J Steroid Biochem Mol Biol 2010;121:403-7.
104. Du T, Zhou Z-G, You S, Huang G, Lin J, Yang L et al. Modulation of monocyte hyperresponsiveness to TLR ligands by 1, 25-dihydroxy-vitamin D3 from LADA and T2DM. Diabetes Res Clin Pract 2009;83:208-14.
105. Do JE, Kwon SY, Park S, Lee E-S. Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease. Rheumatology 2008;47:840-8.
106. Liu PT. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311:1770-3.
107. Biragyn A. Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by beta -Defensin 2. Science 2002;298:1025-9.
108. Griffin MD, Lutz WH, Phan VA, Bachman LA, McKean DJ, Kumar R. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun 2000;270:701-8.
109. Warger T. Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo. Blood 2006;108:544-50.
110. Peng G. Toll-like receptor 8-mediated reversal of CD4 + regulatory T cell function. Science 2005;309:1380-4.
111. Rozkova D, Horvath R, Bartunkova J, Spisek R. Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of toll-like receptors. Clin Immunol 2006;120:260-71.